文献速递脑血管病

黑人与白人卒中后抑郁患者的复发性卒中与死亡风险

Risk of Recurrent Stroke and Mortality Among Black and White Patients With Poststroke Depression.
PubMed 文献 · Stroke · 2024-04-03

基于2016年1月1日至2019年12月31日美国Medicare数据,回顾性队列分析比较黑人及白人卒中后抑郁(PSD)患者复发性卒中与全因死亡风险。在35 604例PSD患者中,黑人患者3年内复发性卒中累积风险持续高于白人患者(log-rank P=0.0011),校正后风险高19.8%(HR 1.198 [95% CI, 1.022-1.405];P=0.0259);全因死亡风险在校正年龄等因素后无显著差异。

要点

  • 黑人PSD患者3年内复发性卒中累积风险持续高于白人PSD患者(log-rank P=0.0011)。
  • 校正社会人口学、合并症、住院特征及急性卒中干预后,黑人患者复发性卒中风险高19.8%(HR 1.198 [95% CI, 1.022-1.405];P=0.0259)。
  • 全因死亡累积风险在老年白人PSD患者中更高,但校正年龄等因素后差异消失。

核心结论

  • 黑人PSD患者复发性卒中风险持续高于白人患者,但全因死亡风险相似。
  • 黑人种族是PSD患者复发性卒中的独立预测因素,需关注影响卒中后结局的健康社会决定因素和系统性种族主义。

研究设计与样本

  • 回顾性队列分析,使用2016年1月1日至2019年12月31日美国Medicare住院、门诊及亚急性护理机构去标识数据。
  • 纳入卒中后6个月内诊断抑郁且卒中前1年无抑郁诊断的黑人和白人患者。
  • 共474 770例急性索引卒中患者,其中443 486例被归类为黑人或不白人种族,35 604例符合PSD标准。
  • PSD队列中25 451例(71.5%)在6个月内无死亡或复发性卒中,5592例(15.7%)在6个月内无死亡或任何原因再入院。

主要发现

  • 黑人PSD患者急性缺血性卒中后3年内复发性卒中累积风险持续高于白人PSD患者(log-rank P=0.0011)。
  • 缩减多变量模型中,黑人患者复发性卒中风险比白人患者高19.8%(HR 1.198 [95% CI, 1.022-1.405];P=0.0259)。
  • 未校正全因死亡累积风险在老年白人PSD患者中高于黑人患者,但校正年龄及其他协变量后差异消失。

临床怎么用

  • 原文结论未给出具体临床推荐,仅指出黑人种族是PSD患者复发性卒中的独立预测因素,并强调需解决影响少数族裔卒中后结局的健康社会决定因素和系统性种族主义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poststroke depression (PSD) is a treatable and common complication of stroke that is underdiagnosed and undertreated in minority populations. We compared outcomes of Black and White patients with PSD in the United States to assess whether race is independently associated with the risk of recurrent stroke and mortality. METHODS: We used deidentified Medicare data from inpatient, outpatient, and subacute nursing facilities for Black and White US patients from January 1, 2016, to December 31, 2019, to perform this retrospective cohort analysis. International Classification of Diseases, Tenth Revision codes were used to identify patients diagnosed with depression within 6 months of index stroke with no depression diagnosis 1-year preceding index stroke. We performed an unadjusted Kaplan-Meier analysis of the cumulative risk of recurrent stroke up to 3 years after index acute ischemic stroke admission and all-cause mortality following acute ischemic stroke stratified by Black and White race. We performed adjusted and reduced Cox regression to calculate hazard ratios for the main predictor of race (Black versus White), for recurrent stroke and all-cause mortality, adjusting for sociodemographic characteristics, comorbidities, characteristics of the hospitalization, and acute stroke interventions. RESULTS: Of 474 770 Medicare patients admitted with acute index stroke, 443 486 were categorized as either Black or White race and 35 604 fulfilled our criteria for PSD. Within the PSD cohort, 25 451 (71.5%) had no death or recurrent stroke within 6 months and 5592 (15.7%) had no death or readmission of any cause within 6 months. Black patients with PSD had a persistently elevated cumulative risk of recurrent stroke compared with White patients with PSD up to 3 years following acute ischemic stroke (log-rank P=0.0011). In our reduced multivariable model, Black patients had a 19.8% (hazard ratio, 1.198 [95% CI, 1.022-1.405]; P=0.0259) greater risk of recurrent stroke than White patients. The unadjusted cumulative risk of all-cause mortality was higher in this cohort of older White patients with PSD compared with Black patients; however, this difference disappeared with adjustment for age and other cofactors. CONCLUSIONS: Black patients with PSD face a persistently elevated risk of recurrent stroke compared with White patients but a similar risk of all-cause mortality. Our findings support that black race is an independent predictor of recurrent stroke in patients with PSD and highlight the need to address social determinants of health and systemic racism that impact poststroke outcomes among racial minorities.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gomberg J, Stein LK, Dhamoon MS, et al. Risk of Recurrent Stroke and Mortality Among Black and White Patients With Poststroke Depression. Stroke. 2024. PMID: 38567535. doi:10.1161/STROKEAHA.123.045743

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。